Israel Englander Incyte Corp Transaction History

Millennium Management LLC

$207 Billion
Q2 2024

A detailed history of Israel Englander (Millennium Management LLC) transactions in Incyte Corp stock. As of the latest transaction made, Millennium Management LLC holds 4,400 shares of INCY stock, worth $356,180. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,400

Previous 834,969 99.47%

Holding current value

$356,180

Previous $47.6 Million 99.44%

% of portfolio

0.0%

Previous 0.02%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$51.18 - $63.75 $21.2 Million - $26.4 Million	-414,667 Reduced 49.66%	420,302 $25.5 Million
Q1 2024 May 15, 2024	SELL	$56.55 - $66.59 $43.1 Million - $50.7 Million	-761,791 Reduced 47.71%	834,969 $47.6 Million
Q4 2023 Feb 14, 2024	BUY	$52.16 - $64.19 $11 Million - $13.6 Million	211,293 Added 15.25%	1,596,760 $100 Million
Q2 2023 Aug 14, 2023	BUY	$60.95 - $75.51 $46.4 Million - $57.4 Million	760,810 Added 121.8%	1,385,467 $86.2 Million
Q1 2023 May 15, 2023	BUY	$70.23 - $86.01 $23.1 Million - $28.3 Million	329,287 Added 111.48%	624,657 $45.1 Million
Q4 2022 Feb 14, 2023	SELL	$67.18 - $84.11 $15.3 Million - $19.2 Million	-228,353 Reduced 43.6%	295,370 $23.7 Million
Q3 2022 Nov 14, 2022	BUY	$66.18 - $82.86 $18.9 Million - $23.6 Million	284,925 Added 119.32%	523,723 $34.9 Million
Q2 2022 Aug 15, 2022	SELL	$66.18 - $83.18 $18 Million - $22.7 Million	-272,549 Reduced 53.3%	238,798 $18.1 Million
Q1 2022 May 16, 2022	SELL	$66.02 - $79.71 $84.1 Million - $102 Million	-1,274,338 Reduced 71.36%	511,347 $40.6 Million
Q4 2021 Feb 14, 2022	BUY	$63.34 - $74.11 $81.9 Million - $95.8 Million	1,292,508 Added 262.08%	1,785,685 $131 Million
Q3 2021 Nov 15, 2021	BUY	$68.67 - $84.02 $996,470 - $1.22 Million	14,511 Added 3.03%	493,177 $33.9 Million
Q2 2021 Aug 16, 2021	SELL	$79.87 - $87.53 $12.3 Million - $13.5 Million	-154,239 Reduced 24.37%	478,666 $40.3 Million
Q1 2021 May 17, 2021	BUY	$76.02 - $100.5 $13.5 Million - $17.9 Million	178,199 Added 39.19%	632,905 $51.4 Million
Q4 2020 Feb 16, 2021	BUY	$80.74 - $97.7 $30.5 Million - $36.8 Million	377,174 Added 486.48%	454,706 $39.6 Million
Q3 2020 Nov 16, 2020	SELL	$85.07 - $109.69 $19.5 Million - $25.2 Million	-229,537 Reduced 74.75%	77,532 $6.96 Million
Q2 2020 Aug 14, 2020	SELL	$74.18 - $108.93 $11.1 Million - $16.3 Million	-149,546 Reduced 32.75%	307,069 $31.9 Million
Q1 2020 May 14, 2020	BUY	$63.18 - $85.97 $12.3 Million - $16.7 Million	194,791 Added 74.4%	456,615 $33.4 Million
Q4 2019 Feb 14, 2020	SELL	$73.04 - $95.72 $1.03 Million - $1.34 Million	-14,036 Reduced 5.09%	261,824 $22.9 Million
Q3 2019 Nov 14, 2019	BUY	$72.82 - $86.52 $19.2 Million - $22.8 Million	263,446 Added 2122.17%	275,860 $20.5 Million
Q2 2019 Aug 15, 2019	SELL	$73.52 - $88.7 $4.57 Million - $5.51 Million	-62,125 Reduced 83.35%	12,414 $1.06 Million
Q2 2019 Aug 14, 2019	SELL	$73.52 - $88.7 $22.8 Million - $27.5 Million	-310,483 Reduced 80.64%	74,539 $12.1 Million
Q1 2019 May 14, 2019	SELL	$63.56 - $88.17 $35.9 Million - $49.8 Million	-564,787 Reduced 59.46%	385,022 $33.1 Million
Q4 2018 Feb 14, 2019	SELL	$58.5 - $69.94 $4.83 Million - $5.77 Million	-82,550 Reduced 8.0%	949,809 $60.4 Million
Q3 2018 Nov 14, 2018	SELL	$61.75 - $74.23 $3.25 Million - $3.91 Million	-52,674 Reduced 4.85%	1,032,359 $71.3 Million
Q2 2018 Aug 14, 2018	BUY	$60.85 - $83.98 $48.4 Million - $66.9 Million	796,208 Added 275.67%	1,085,033 $72.7 Million
Q1 2018 May 15, 2018	SELL	$83.06 - $100.98 $6.16 Million - $7.48 Million	-74,112 Reduced 20.42%	288,825 $24.1 Million
Q4 2017 Feb 14, 2018	BUY	$93.56 - $116.6 $1.98 Million - $2.47 Million	21,205 Added 6.21%	362,937 $34.4 Million
Q3 2017 Nov 14, 2017	BUY	$109.15 - $138.27 $37.3 Million - $47.3 Million	341,732	341,732 $39.9 Million

Others Institutions Holding INCY

# of Institutions

624

Shares Held

198M

Call Options Held

766K

Put Options Held

476K

View Full List

About INCYTE CORP

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $18B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

More about INCY

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account